Molecular Therapy: Nucleic Acids (Jan 2012)

Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing

  • Christian Dohmen,
  • Thomas Fröhlich,
  • Ulrich Lächelt,
  • Ingo Röhl,
  • Hans-Peter Vornlocher,
  • Philipp Hadwiger,
  • Ernst Wagner

DOI
https://doi.org/10.1038/mtna.2011.10
Journal volume & issue
Vol. 1, no. C

Abstract

Read online

Gene silencing mediated by small interfering RNA (siRNA) is a novel approach in the development of new cancer therapeutics. Polycations used for nucleic acid delivery still remain heterogeneous compounds, despite continuous progress in polymer synthetic technologies. Here we report the development of a structural defined folic acid polyethylene glycol (PEG) siRNA conjugate accessible via click chemistry yielding a monodisperse ligand-PEG-siRNA conjugate. The folic acid targeting ligand was synthesized by solid phase supported peptide chemistry. The conjugate was shown to be specifically internalized into folic acid receptor expressing cells. When combined with a structurally defined polycation, again synthesized with the precision of solid phase chemistry, efficient receptor specific gene silencing is achieved.